ATE230596T1 - Verwendung von granisetron zur behandlung von postoperativer übelkeit und erbrechen - Google Patents

Verwendung von granisetron zur behandlung von postoperativer übelkeit und erbrechen

Info

Publication number
ATE230596T1
ATE230596T1 AT94911178T AT94911178T ATE230596T1 AT E230596 T1 ATE230596 T1 AT E230596T1 AT 94911178 T AT94911178 T AT 94911178T AT 94911178 T AT94911178 T AT 94911178T AT E230596 T1 ATE230596 T1 AT E230596T1
Authority
AT
Austria
Prior art keywords
granisetron
vomiting
postoperative nausea
treat postoperative
treat
Prior art date
Application number
AT94911178T
Other languages
English (en)
Inventor
Gareth John Sanger
Philip Timothy Davey
Christopher Stuart Dott
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10732290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE230596(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE230596T1 publication Critical patent/ATE230596T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatment Of Sludge (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT94911178T 1993-03-18 1994-03-15 Verwendung von granisetron zur behandlung von postoperativer übelkeit und erbrechen ATE230596T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939305593A GB9305593D0 (en) 1993-03-18 1993-03-18 Pharmaceuticals
PCT/EP1994/000820 WO1994021257A1 (en) 1993-03-18 1994-03-15 Use of granisetron for the treatment of post-operative nausea and vomiting

Publications (1)

Publication Number Publication Date
ATE230596T1 true ATE230596T1 (de) 2003-01-15

Family

ID=10732290

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94911178T ATE230596T1 (de) 1993-03-18 1994-03-15 Verwendung von granisetron zur behandlung von postoperativer übelkeit und erbrechen

Country Status (21)

Country Link
US (1) US5952340A (de)
EP (1) EP0689437B1 (de)
JP (2) JP3792251B2 (de)
KR (1) KR100315606B1 (de)
CN (1) CN1085079C (de)
AP (1) AP511A (de)
AT (1) ATE230596T1 (de)
AU (1) AU676032B2 (de)
CA (1) CA2158354C (de)
CY (1) CY2427B1 (de)
DE (1) DE69431986T2 (de)
DK (1) DK0689437T3 (de)
ES (1) ES2188611T3 (de)
GB (1) GB9305593D0 (de)
HK (1) HK1012237A1 (de)
HU (1) HU214629B (de)
IL (1) IL109059A (de)
SG (1) SG46724A1 (de)
TW (1) TW312622B (de)
WO (1) WO1994021257A1 (de)
ZA (1) ZA941844B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412995D0 (en) * 1994-06-28 1994-10-26 Prendergast Kenneth F Safety enhancing pharmaceutical compositions of an active indazole
AU2003237657A1 (en) * 2002-05-24 2003-12-12 Epidauros Biotechnologie Ag Means and methods for improved treatment using "setrones"
SE0203410D0 (sv) * 2002-11-18 2002-11-18 Astrazeneca Ab New use
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
TWI355936B (en) 2003-02-18 2012-01-11 Helsinn Healthcare Sa Uses of palonosetron hydrochloride
GB0328186D0 (en) * 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
JP6081102B2 (ja) * 2012-08-10 2017-02-15 テルモ株式会社 安定なグラニセトロン含有水性製剤
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
JP2017077484A (ja) * 2016-11-30 2017-04-27 テルモ株式会社 安定なグラニセトロン含有水性製剤の包装体
GB201702250D0 (en) 2017-02-10 2017-03-29 Acacia Pharma Ltd Method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0200444B1 (de) * 1985-04-27 1992-11-11 Beecham Group Plc Azabicyclononyl-indazol-carboxamid mit 5-HT-antagonistischer Wirkung
GB8525913D0 (en) * 1985-10-21 1985-11-27 Beecham Group Plc Compounds
GB8928837D0 (en) * 1989-12-21 1990-02-28 Beecham Group Plc Pharmaceuticals
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
PT533280E (pt) * 1991-09-20 2001-01-31 Glaxo Group Ltd Novas utilizacoes medicas para antagonistas de taquiquinina

Also Published As

Publication number Publication date
AP9400626A0 (en) 1994-04-30
ES2188611T3 (es) 2003-07-01
HK1012237A1 (en) 1999-07-30
IL109059A0 (en) 1994-11-28
DE69431986D1 (de) 2003-02-13
HUT73502A (en) 1996-08-28
ZA941844B (en) 1995-09-18
EP0689437B1 (de) 2003-01-08
IL109059A (en) 1996-11-14
CN1085079C (zh) 2002-05-22
SG46724A1 (en) 1998-02-20
US5952340A (en) 1999-09-14
HU9502692D0 (en) 1995-11-28
EP0689437A1 (de) 1996-01-03
JP3792251B2 (ja) 2006-07-05
JP2006083190A (ja) 2006-03-30
CA2158354A1 (en) 1994-09-29
CA2158354C (en) 2004-07-13
JPH08507774A (ja) 1996-08-20
KR100315606B1 (ko) 2002-04-24
AU6377494A (en) 1994-10-11
DK0689437T3 (da) 2003-04-28
WO1994021257A1 (en) 1994-09-29
CN1122570A (zh) 1996-05-15
HU214629B (hu) 1998-04-28
TW312622B (de) 1997-08-11
GB9305593D0 (en) 1993-05-05
CY2427B1 (en) 2004-11-12
AU676032B2 (en) 1997-02-27
AP511A (en) 1996-07-26
DE69431986T2 (de) 2003-11-06

Similar Documents

Publication Publication Date Title
DE69704877T2 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung und prophylaxe der multiplen sclerose
DE69329071D1 (de) Zusammensetzung und verfahren zur erhöhten düngeraufnahme von pflanzen
DE69429336T2 (de) Zusammensetzung von Pflanzenwachstums-Beschleuniger
DE69426690D1 (de) Behandlung von atrophischer Haut und Vagina
DE69115921D1 (de) Verfahren zur behandlung und verwendung von abfallstoffen
DE69422842T2 (de) Verfahren und Einrichtung zur Behandlung von Lithium
DE69425131D1 (de) Verwendung von clavulansäure und einem antibiotikum zur behandlung von infektionen
ATE230596T1 (de) Verwendung von granisetron zur behandlung von postoperativer übelkeit und erbrechen
DE69716896D1 (de) Substituierte benzylamine-derivate und ihre verwendung zur behandlung von depression
NO172838C (no) Fremgangsmaate og anlegg for behandling av avfallsprodukter
DE4392300T1 (de) Therapeutische Gebräuche von beißenden Pflanzen und Ihre Verwandten Zusammensetzungen
DE69614739T2 (de) Pflaster zur Behandlung von Pflanzen
ATE190486T1 (de) Verwendung von buckminsterfulleren zur behandlung neurotoxischer verletzungen
BR9306359A (pt) Azocorantes aplicação do azocorante e modificação cristalina
DE69607417T2 (de) Verwendung von Batroxobin enthaltende Arzneimittel zur Behandlung und Prophylaxe von ischämischen Reperfusionsschäden
DE69412178T2 (de) Apparat zur Behandlung von Lagen
DE3586420D1 (de) Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose.
ATE216885T1 (de) Verwendung von penciclovir zur behandlung von postherpetischer neuralgie
DE29708955U1 (de) Anlage zur Erzeugung und Nutzung von Biogas
ATE224711T1 (de) Formulierung zur behandlung und/oder vorbeugung von dementia
DE69309582D1 (de) Endlos Formularsatz und dadurch erstelltes Poststück
DE69232918D1 (de) Verwendung von Carbachol zur Behandlung verringerter willkürlicher Mobilität
DE3881377D1 (de) Mittel zur prophylaxe und behandlung von thrombocytopenie.
DE69117566T2 (de) Verwendung von Isomonoolen zur Behandlung und Prophylaxe von Krebserkrankungen
DE3891230T1 (de) Anlage zur chirurgischen behandlung der ametropie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0689437

Country of ref document: EP

RZN Patent revoked